CELLTRANS

CellTrans is a faculty start-up company launched out of Dr. José Oberholzer's scientific research group at the University of Illinois. Dr. Oberholzer has led the Islet Transplant Program at the University of Illinois since August of 2003 and his team has completed over 600 islet isolations as well as successful Phase I, II, and III clinical trials for islet transplantation. CellTrans aims to bring cell-based therapies including isolated islets, encapsulated islets, and human derived stem-cells to clinical application to combat the global epidemic of diabetes and other endocrine disorders... CellTrans provides world-class services for autologous and allogeneic islet isolations for the purpose of clinical transplantation... CellTrans has unique expertise in complex in vitro cell product assessments. We can help you develop batch release testing for your cellular product.

Also known as: CellTrans Inc

Primary location: Chicago United States